Posters
CKM: Clinical - Trials, Epidemiology, and Biomarkers
October 23, 2026 | 10:00 AM - 12:00 PM
Location: Exhibit Hall A, Convention Center
Session Description
Poster Session
Posters
Formoterol as a Treatment for Diabetic Nephropathy (and Metabolic Dysfunction-Associated Steatohepatitis): A New Clinical Trial
Baxdrostat/Dapagliflozin vs. Placebo/Dapagliflozin in Adults with CKD with Hypertension: BaxDuo-Arctic Phase 3 Study Design and Baseline Characteristics
Empagliflozin in Patients with Moderate-to-Advanced CKD, Acutely Decompensated Heart Failure, and Diuretic Resistance: The DRIP-AHF Clinical Trial
Effects of Empagliflozin on Plasma Ceramide Levels in Patients Treated with Long-Term Hemodialysis
SGLT2 Inhibitor Therapy Attenuates Endothelial Glycocalyx Injury and Reduces Interstitial Fluid Volume in Patients with CKD and Fluid Retention: The DAPA-BODY Trial
Effects of SGLT2 Inhibitors on YKL-40 Levels in Diabetic Kidney Disease
Dapagliflozin Reduces KIM-1 in Nondiabetic Individuals with Obesity and Insulin Resistance: A Randomized, Double-Blind, Crossover Trial
Finerenone in Patients with CKD by SGLT2 Inhibitor Treatment: A FIND-CKD Analysis
Finerenone in Asian Patients with CKD: A FIND-CKD Analysis
Finerenone in Patients with CKD and Type 1 Diabetes According to Geographic Region: A FINE-ONE Analysis
Effects of the Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone on the Renal Hemodynamic and Intraglomerular Profile in Patients with Type 2 Diabetes
Renal Autologous Cell Therapy for CKD with Diabetes: Pooled Safety and Efficacy Results from a Phase 2 Program in a Subset of Participants with Key Phase 3 Eligibility Characteristics
Effect of Oral Semaglutide on Residual Albuminuria in Patients with Diabetic Kidney Disease Despite Standard Nephroprotective Therapy
Retatrutide Increases Serum Uromodulin (UMOD) in People with Obesity with or Without Type 2 Diabetes and Without Kidney Disease
Is Angiotensin Receptor-Neprilysin Inhibitor (ARNI) the Magic Wand? A Single-Centre, Double-Blind, Randomised, Active-Controlled Study to Evaluate the Efficacy and Safety of ARNI vs. ARB in Patients with CKD and Heart Failure on Maintenance Hemodialysis (MHD)
Effects of Lumasiran in Patients with Hyperoxalemia on Maintenance Haemodialysis
Effect of High-Dose Cholecalciferol on Mortality in Patients on Dialysis: Results of the SIMPLIFIED Trial
Lime Extract Reduces Albuminuria and Protects Kidney Function in Diabetic Kidney Disease
Ertugliflozin Effects on Cardiovascular, Kidney, and Inflammatory Biomarkers in VERTIS CV: Exploratory Analyses
Baxdrostat Effects in CKD with Uncontrolled Hypertension: Biomarker Analysis Results from the Phase 2 FigHTN Trial
Clinical Phenotypes and Outcomes of Cardiovascular Disease in a Real-World CKD Cohort: A Retrospective Analysis
Heterogeneity in Blood Pressure Response to Urinary Sodium and Potassium by Age and Hypertension Polygenic Risk
Association of Coronary Artery Calcification with Serum Markers of Endothelial Activation and Damage in Patients with CKD: The CRIC Study
Cellular and Molecular Features and Clinical Significance of Tertiary Lymphoid Structures in Diabetic Kidney Disease
Association of Arterial Vascular Endothelial Growth Factor C Positivity with Arteriosclerotic Changes in Kidney Biopsy Specimens
Nuclear Magnetic Resonance (NMR) Metabolomics Improves Prediction of CKD and Downstream Complications in Health-System and Population Biobanks
Biomarkers of Kidney Injury and their Relevance to D-Dimer Levels in Patients with ESKD on Hemodialysis
Apelin-13 Outperforms Asymmetric Dimethylarginine in Predicting Mortality in Patients on Hemodialysis
sST2-Treg Axis in Cardiac Surgery-Associated AKI (CSA-AKI)
Kidney Tubular Function and Adverse Outcomes in CKD
Ang2/Ang1 Ratio as an Independent Cardiovascular Risk Predictor in Patients with Hypertension and CKD
B-Type Natriuretic Peptide (BNP) Association with CKD and AKI
Four eGFR-Dependent Proteomic Trajectories of Incident Myocardial Infarction Across the Kidney Function Spectrum: A UK Biobank Proteome-Wide Association Study
Urinary Transcriptomic Analysis to Identify New Markers of Kidney Injury in Patients with Diabetes
Urinary Dickkopf-3 Concentration and Kidney Function Decline in Adults with Type 2 Diabetes: A Prospective Cohort Study
Urinary Proteomic Signatures Distinguish Diabetic Kidney Disease from Diabetes and Healthy Controls
Urinary Succinate and Kidney Injury in Type 2 Diabetes Mellitus: A Cross-Sectional Analysis
Urinary Kallistatin as a Novel Biomarker and Independent Predictor of Cardiorenal outcomes in Patients with Type 2 Diabetes and CKD
Urinary Proteome, Integrated Analyses, and Kidney Disease Progression in Type 1 Diabetes
Gut Microbiota-Derived Metabolites and Peripheral Artery Disease in Patients on Hemodialysis: Insights into the Gut-Vascular Axis
Associations of P-Cresol Sulfate with Heart Rate Variability in the Chronic Renal Insufficiency Cohort Study
Glycemic Markers and Kidney Function Decline in Type 2 Diabetes
Noninvasive Metabolic-Autonomic Phenotyping Using Skin Autofluorescence and Fractal Heart Rate Dynamics for Risk Stratification in Diabetic Kidney Disease
Dietary Inflammatory Index and All-Cause Mortality in Adults with Cardiovascular-Kidney-Metabolic Syndrome
Association of Peptidase Inhibitor 3 (PI3) with Kidney Outcomes in Heart Failure with Preserved Ejection Fraction (HFpEF) and Attenuation by Spironolactone
Associations of Continuous Glucose Monitor Metrics with Biomarkers of Tubular Injury
Single-Cell RNA Sequencing Dissociates the Kidney Transcriptional Signatures of Obesity and Type 1 Diabetes in Young Persons, Potentially Supporting Combined Glycemic and Adiposity-Directed Therapy
Plasma Proteogenomics Identifies Glucose-Independent Residual Risk Drivers in Diabetic Kidney Disease
Proteomic Signatures of Adiposity in Type 1 Diabetes Associated with Kidney Oxygenation
Proteomic Determinants of Diastolic Dysfunction and the Mediating Role of Kidney Function
Tumor Necrosis Factor Receptor Signaling in Response to SGLT2 Inhibition in Kidney Transplant Recipients: An Analysis of the INFINITI Trial
Cardiovascular Morbidity and Mortality in Hemodialysis: In Addition to Traditional Risk Factors, Chronic Inflammation, Complement Activation, and Biocompatibility Are Also in Focus
Association of Kidney Tubule Health with Incident Cardiovascular Events in Community-Living Adults
Renoprotective Potential of Micronized Purified Flavonoid Fraction in Diabetic Kidney Disease: ANCOVA Adjusted for ACE Inhibitor/ARB/Finerenone and SGLT2 Inhibitor Use
Association Between Urinary Sodium-to-Potassium Ratio and Antiproteinuric Effects of Finerenone in Patients with Diabetic Kidney Disease: A Retrospective Study
Anemia and Incident Cardiovascular Events in Patients with CKD
Cluster Analysis of Routine Clinical Variables Identifies High-Risk Phenotypes for Rapid Progression of Diabetic Kidney Disease
Sex- and Age-Specific Cardiometabolic Comorbidity Patterns in Hospitalized Adults with CKD Stage 4
Prevalence of CKD in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Sodium-Glucose Cotransporter 2 Inhibitors Among Middle-Aged and Older Adults with Lupus Nephritis
Prevalence and Temporal Trends of Cardiovascular-Kidney-Metabolic Syndrome Among Chinese Inpatients Undergoing Kidney Biopsy